Heledd Lewis
Datos Biográficos
| ID | 3801400 |
|---|---|
| NOMBRE | Heledd Lewis |
| NOMBRES | Heledd |
| APELLIDO | Lewis |
| FIRMA | LEWIS H |
| AFILIACIONES | Cardiff University |
| ORCID | 0000-0003-4536-3596 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 1 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2025 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2025 |
| ÍNDICE H | 0 |
A qualitative exploration of the experiences of adults with cystic fibrosis unable to benefit from triple combination therapy
Elexacaftor/Tezacaftor/Ivacaftor (ETI) is a highly effective modulator therapy that has transformed the lives of many people with Cystic Fibrosis (CF). However, limited research has explored the experiences of those not able to benefit from ETI due to genetic factors. Seven adults with CF participated in semi-structured interviews, and data were analysed using Interpretative Phenomenological Analysis (IPA). Four themes emerged: 'feeling forgotten…
Sin obras prominentes en esta página.
A qualitative exploration of the experiences of adults with cystic fibrosis unable to benefit from triple combination therapy
Elexacaftor/Tezacaftor/Ivacaftor (ETI) is a highly effective modulator therapy that has transformed the lives of many people with Cystic Fibrosis (CF). However, limited research has explored the experiences of those not able to benefit from ETI due to genetic factors. Seven adults with CF participated in semi-structured interviews, and data were analysed using Interpretative Phenomenological Analysis (IPA). Four themes emerged: 'feeling forgotten…
Cystic Fibrosis Research Advances (1 obras)